Pimavanserin - CaLiGraph

CaLiGraph

Property	Value
rdf:type	Urea 5-HT2A antagonist owl:NamedIndividual Atypical antipsychotic Fluoroarene Piperidine Psychoactive drug Investigational antidepressant Phenol ether Drug granted breakthrough therapy designation
rdfs:label	Pimavanserin
owl:sameAs	dbr:Pimavanserin
prov:wasDerivedFrom	http://en.wikipedia.org/wiki/Antipsychotic http://en.wikipedia.org/wiki/Category:Atypical_antipsychotics http://en.wikipedia.org/wiki/List_of_antipsychotics http://en.wikipedia.org/wiki/List_of_psychotropic_medications http://en.wikipedia.org/wiki/Category:Ureas http://en.wikipedia.org/wiki/Category:5-HT2A_antagonists http://en.wikipedia.org/wiki/5-HT2A_receptor http://en.wikipedia.org/wiki/Category:Fluoroarenes http://en.wikipedia.org/wiki/Category:Piperidines http://en.wikipedia.org/wiki/List_of_drugs_granted_breakthrough_therapy_designation http://en.wikipedia.org/wiki/Category:Phenol_ethers http://en.wikipedia.org/wiki/List_of_investigational_antidepressants
skos:prefLabel	Pimavanserin
skos:altLabel	Pimavanserin (ACP-103) pimavanserin
clgo:alternativeName	Nuplazid
clgo:casNumber	706779-91-1 706782-28-7 (tartrate)
clgo:chEBI	133017
clgo:chEMBL	2111101
clgo:drugbank	DB05316
clgo:fdaUniiCode	JZ963P0DIK
clgo:kegg	D08969
clgo:pubchem	10071196
is clgo:product of	Acadia Pharmaceuticals

About: clgr:Pimavanserin